COMMUNIQUÉS West-GlobeNewswire

Alder BioPharmaceuticals® to Present New Data Further Highlighting Eptinezumab’s Efficacy Profile for Migraine Prevention at American Headache Society Meeting
20/06/2018
New eptinezumab data at two late-breaking sessions demonstrate efficacy that is sustained and further improved after repeat treatments BOTHELL, Wash., June 20, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. ( [...]
Emblem to Launch Emblem Germany in Joint Venture with Acnos Pharma
20/06/2018
TORONTO, June 20, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (TSXV:EMC.WT) (OTCBB:EMMBF) (“Emblem” or the “Company”), is pleased to announce that its Board of Directors has approved the Company’s formation of a [...]
PositiveID CEO Details New Distribution Agreement with Leading Non-Invasive Patient Monitoring Technology Company
20/06/2018
Agreement for new Bluetooth thermometer and other topics discussed in interview with CEOLIVE.TV DELRAY BEACH, Fla., June 20, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (the “Company”) (OTC:PSID), a life sciences [...]
HealthEC Announces Beaumont Health as New Client for Population Health Management Solution
20/06/2018
Beaumont Cites Breadth of HealthEC’s Data Aggregation and Analytics Capabilities as Key Reasons for Joining Platform PISCATAWAY, N.J., June 20, 2018 (GLOBE NEWSWIRE) -- HealthEC , which earned the highest overall vendor [...]
WishBone Medical, Inc. announces Randal R. Betz, M.D. as Chief Medical Officer
20/06/2018
WARSAW, Ind., June 20, 2018 (GLOBE NEWSWIRE) -- WishBone Medical, Inc. is pleased to announce the appointment of Randal R. Betz, M.D. as Chief Medical Officer. Dr. Betz, on a part time consulting basis, will provide [...]
OncBioMune to Commence Phase 2 Trial of ProscaVax for Early Stage Prostate Cancer Patients
20/06/2018
BATON ROUGE, La., June 20, 2018 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]
Samumed Presents Clinical and Preclinical Data at European League Against Rheumatism (EULAR) 2018 Annual Congress
20/06/2018
Phase 2 data in osteoarthritis and preclinical data in tendinopathy and psoriasis demonstrated the emerging breadth of the Samumed pipeline in arthritis related diseases and in dermatology SAN DIEGO, June 20, 2018 ( [...]
Cianna Medical Showcased the SAVI SCOUT® Radar Breast Localization System at Premier Inc.’s Annual Breakthroughs Conference
20/06/2018
ALISO VIEJO, Calif., June 20, 2018 (GLOBE NEWSWIRE) -- Cianna Medical’s SAVI SCOUT ® Radar Breast Localization System is one of the medical innovations that was showcased in front of thousands of healthcare providers at [...]
Moleculin Receives Approval for Leukemia Clinical Trial
20/06/2018
HOUSTON, June 20, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq:MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of [...]
TG Therapeutics and Novimmune SA Announce Global Agreement for Development and Commercialization of a Novel Anti-CD47/ Anti-CD19 Bispecific Antibody
20/06/2018
NEW YORK, June 20, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX) and Novimmune SA, today announced that the companies have entered into an exclusive global agreement to collaborate on the development and [...]
Kura Oncology Appoints Chief Operating Officer, Expands Clinical Development Team as Company Prepares for First Registration-Directed Trial
20/06/2018
– John Farnam appointed to newly created position of Chief Operating Officer – – Bridget Martell, M.D., and Blake Tomkinson, Ph.D., join as Vice Presidents of Clinical Development – – Registration-directed trial of [...]
Restoration Robotics™ to Sponsor and Participate in The Aesthetic Show™ 2018
20/06/2018
SAN JOSE, Calif., June 20, 2018 (GLOBE NEWSWIRE) -- Restoration Robotics, Inc. (NASDAQ:HAIR), the global leader in robotic hair restoration, today announced that the Company will be a Premier Sponsor, deliver multiple [...]
genedrive plc: Grant to develop and implement a point-of-care test in the NHS to avoid antibiotic-related hearing loss in newborn children
20/06/2018
For release: 20 June 2018 The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the [...]
iTeos Therapeutics Completes $75 Million Series B Financing
20/06/2018
iTeos Therapeutics Completes $75 Million Series B Financing Oversubscribed financing round led by new U.S. investor MPM Capital Proceeds to support accelerated development of innovative next-generation immuno-oncology [...]
Orion Corporation: Managers' transactions - Nina Karvonen
20/06/2018
ORION CORPORATION MANAGERS' TRANSACTIONS 20 June 2018 at 12.00 EEST Orion Corporation: Managers' transactions - Nina Karvonen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No [...]
Orion Corporation: Managers' transactions - Anne Karvonen
20/06/2018
ORION CORPORATION MANAGERS' TRANSACTIONS 20 June 2018 at 11.45 EEST Orion Corporation: Managers' transactions - Anne Karvonen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No [...]
ObsEva Announces Pricing of Follow-on Public Offering
20/06/2018
Geneva, Switzerland and Boston, MA - June 20, 2018 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions [...]
Solon Eiendom ASA : Primary insider notification
20/06/2018
(Oslo, Norway, June 19, 2018) UFI AS has today bought 74.688 shares in Solon Eiendom ASA at a price of NOK 29.7396 per share. Solon Eiendom ASA Board Member Øystein A. Landvik owns 33,34 % of the shares in UFI AS. [...]
Publication of offer document by Nordic Transport Group Holding A/S
20/06/2018
Company Announcement 20 June 2018 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH [...]

Pages